MIRSA GARCIA: Open Payments
NPI 1790373967 · RIO GRANDE CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 50 payments from 12 companies in 2025. Trend: 2023 $28 · 2024 $218 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $392 |
| Sumitomo Pharma America, Inc. | 9 | $269 |
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| Amgen Inc. | 3 | $51 |
| Verona Pharma, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
Products named: VRAYLAR, GEMTESA, FARXIGA, UBRELVY, BREZTRI, Ohtuvayre, MOUNJARO, EVENITY.
Industry payments across TX — which companies pay providers there.
